Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 EUR | +2.48% | -0.80% | +2.90% |
04-22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
04-11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
Transcripts
- Stock Market
- Equities
- ADMIN Stock
- News Administer Oyj
- Transcripts